These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 27613071)
1. Lack of clinically useful response predictors for treating aggression and agitation in Alzheimer's disease with citalopram. Herrmann N Evid Based Ment Health; 2016 Nov; 19(4):e24. PubMed ID: 27613071 [No Abstract] [Full Text] [Related]
2. Heterogeneity of Treatment Response to Citalopram for Patients With Alzheimer's Disease With Aggression or Agitation: The CitAD Randomized Clinical Trial. Schneider LS; Frangakis C; Drye LT; Devanand DP; Marano CM; Mintzer J; Mulsant BH; Munro CA; Newell JA; Pawluczyk S; Pelton G; Pollock BG; Porsteinsson AP; Rabins PV; Rein L; Rosenberg PB; Shade D; Weintraub D; Yesavage J; Lyketsos CG; Am J Psychiatry; 2016 May; 173(5):465-72. PubMed ID: 26771737 [TBL] [Abstract][Full Text] [Related]
3. Treating agitation and aggression in patients with Alzheimer's disease with escitalopram. Žmuc Veranič L; Pregelj P; Jerin A Psychogeriatrics; 2016 Nov; 16(6):384-385. PubMed ID: 26551073 [No Abstract] [Full Text] [Related]
6. Role of citalopram in the treatment of agitation in Alzheimer's disease. Porsteinsson AP; Keltz MA; Smith JS Neurodegener Dis Manag; 2014; 4(5):345-9. PubMed ID: 25405648 [TBL] [Abstract][Full Text] [Related]
7. When and How to Treat Agitation in Alzheimer's Disease Dementia With Citalopram and Escitalopram. Aga VM Am J Geriatr Psychiatry; 2019 Oct; 27(10):1099-1107. PubMed ID: 31288974 [TBL] [Abstract][Full Text] [Related]
8. Citalopram decreases agitation in the context of Alzheimer's disease, but at doses higher than those commonly prescribed and at the expense of side effects. Underwood BR; Fox C Evid Based Med; 2014 Oct; 19(5):181. PubMed ID: 24824622 [No Abstract] [Full Text] [Related]
12. Calming Alzheimer's agitation: a promising drug. Johns Hopkins Med Lett Health After 50; 2014 Jun; 29(5):8. PubMed ID: 25097959 [No Abstract] [Full Text] [Related]
14. Longitudinal Course of Agitation and Aggression in Patients with Alzheimer's Disease in a Cohort Study: Methods, Baseline and Longitudinal Results of the A3C Study. De Mauleon A; Delrieu J; Cantet C; Vellas B; Andrieu S; Rosenberg PB; Lyketsos CG; Soto Martin M J Prev Alzheimers Dis; 2021; 8(2):199-209. PubMed ID: 33569568 [TBL] [Abstract][Full Text] [Related]
15. Use of psychotropic agents to treat agitation and aggression in Brazilian patients with Alzheimer's disease: A naturalistic and multicenter study. Oliveira LF; Camargos EF; Martini LLL; Machado FV; Novaes MRCG Psychiatry Res; 2021 Jan; 295():113591. PubMed ID: 33271491 [TBL] [Abstract][Full Text] [Related]
16. Treating dementia and agitation. Small GW JAMA; 2014 Feb; 311(7):677-8. PubMed ID: 24549545 [No Abstract] [Full Text] [Related]
18. Efficacy and Safety of Citalopram Compared to Atypical Antipsychotics on Agitation in Nursing Home Residents With Alzheimer Dementia. Viscogliosi G; Chiriac IM; Ettorre E J Am Med Dir Assoc; 2017 Sep; 18(9):799-802. PubMed ID: 28739492 [TBL] [Abstract][Full Text] [Related]
19. Advancements in the treatment of agitation in Alzheimer's disease. Antonsdottir IM; Smith J; Keltz M; Porsteinsson AP Expert Opin Pharmacother; 2015; 16(11):1649-56. PubMed ID: 26159445 [TBL] [Abstract][Full Text] [Related]
20. R- and S-citalopram concentrations have differential effects on neuropsychiatric scores in elders with dementia and agitation. Ho T; Pollock BG; Mulsant BH; Schantz O; Devanand DP; Mintzer JE; Porsteinsson AP; Schneider LS; Weintraub D; Yesavage J; Drye LT; Munro CA; Shade DM; Lyketsos C; Bies R Br J Clin Pharmacol; 2016 Sep; 82(3):784-92. PubMed ID: 27145364 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]